Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P R Greipp

Showing results (91-100 of 178) with videos related to

Pageof 18
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 1999
Prospective randomized trial of melphalan and prednisone versus vincristine, carmustine, melphalan, cyclophosphamide, and prednisone in the treatment of primary systemic amyloidosisM A Gertz, M Q Lacy, J A Lust, et al.
Blood|September 1, 1996
Peripheral blood monoclonal plasma cells as a predictor of survival in patients with multiple myelomaT E Witzig, M A Gertz, J A Lust, et al.
American Journal of Hematology|April 1, 1989
Detection of hypodiploidy using multi-parameter flow cytometric analysis: a prognostic indicator in multiple myelomaR J Morgan, N J Gonchoroff, J A Katzmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1988
Peripheral blood B cell labeling indices are a measure of disease activity in patients with monoclonal gammopathiesT E Witzig, N J Gonchoroff, J A Katzmann, et al.
Medical Oncology (Northwood, London, England)|August 24, 1999
Phase II trial of high-dose dexamethasone for untreated patients with primary systemic amyloidosisM A Gertz, M Q Lacy, J A Lust, et al.
American Journal of Hematology|June 15, 1999
Phase II trial of high-dose dexamethasone for previously treated immunoglobulin light-chain amyloidosisM A Gertz, M Q Lacy, J A Lust, et al.
Blood|June 15, 1993
Plasma cell labeling index and beta 2-microglobulin predict survival independent of thymidine kinase and C-reactive protein in multiple myelomaP R Greipp, J A Lust, W M O'Fallon, et al.
Leukemia|May 1, 1996
Establishment and characterization of three myeloma cell lines that demonstrate variable cytokine responses and abilities to produce autocrine interleukin-6J J Westendorf, G J Ahmann, P R Greipp, et al.
Cytokine|March 1, 1992
Isolation of an mRNA encoding a soluble form of the human interleukin-6 receptorJ A Lust, K A Donovan, M P Kline, et al.
Journal of Cellular Biochemistry|January 1, 1986
Amplification of RNA and DNA specific for erb B in unbalanced 1;7 chromosomal translocation associated with myelodysplastic syndromeG E Woloschak, G W Dewald, R S Bahn, et al.
Pageof 18

Showing results (91-100 of 178) with videos related to

Sort By:
Pageof 18
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 1999
Prospective randomized trial of melphalan and prednisone versus vincristine, carmustine, melphalan, cyclophosphamide, and prednisone in the treatment of primary systemic amyloidosisM A Gertz, M Q Lacy, J A Lust, et al.
Blood|September 1, 1996
Peripheral blood monoclonal plasma cells as a predictor of survival in patients with multiple myelomaT E Witzig, M A Gertz, J A Lust, et al.
American Journal of Hematology|April 1, 1989
Detection of hypodiploidy using multi-parameter flow cytometric analysis: a prognostic indicator in multiple myelomaR J Morgan, N J Gonchoroff, J A Katzmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1988
Peripheral blood B cell labeling indices are a measure of disease activity in patients with monoclonal gammopathiesT E Witzig, N J Gonchoroff, J A Katzmann, et al.
Medical Oncology (Northwood, London, England)|August 24, 1999
Phase II trial of high-dose dexamethasone for untreated patients with primary systemic amyloidosisM A Gertz, M Q Lacy, J A Lust, et al.
American Journal of Hematology|June 15, 1999
Phase II trial of high-dose dexamethasone for previously treated immunoglobulin light-chain amyloidosisM A Gertz, M Q Lacy, J A Lust, et al.
Blood|June 15, 1993
Plasma cell labeling index and beta 2-microglobulin predict survival independent of thymidine kinase and C-reactive protein in multiple myelomaP R Greipp, J A Lust, W M O'Fallon, et al.
Leukemia|May 1, 1996
Establishment and characterization of three myeloma cell lines that demonstrate variable cytokine responses and abilities to produce autocrine interleukin-6J J Westendorf, G J Ahmann, P R Greipp, et al.
Cytokine|March 1, 1992
Isolation of an mRNA encoding a soluble form of the human interleukin-6 receptorJ A Lust, K A Donovan, M P Kline, et al.
Journal of Cellular Biochemistry|January 1, 1986
Amplification of RNA and DNA specific for erb B in unbalanced 1;7 chromosomal translocation associated with myelodysplastic syndromeG E Woloschak, G W Dewald, R S Bahn, et al.
Pageof 18